Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Coca

Showing results (21-30 of 257) with videos related to

Pageof 26
Sort By:
Lancet (London, England)|October 3, 2003
COMET: a proposed mechanism of action to explain the results and concerns about doseSteven G Coca, Gregory K Buller
The American Journal of the Medical Sciences|October 20, 2005
The role of aldosterone blockers in the management of chronic heart failureSteven G Coca, Mark A Perazella
The New England Journal of Medicine|July 9, 2003
Eplerenone in patients with left ventricular dysfunctionSteven G Coca, Gregory K Buller
Seminars in Dialysis|March 27, 2014
Can we predict recovery from severe acute kidney injury with biomarkers?Farrukh M Koraishy, Steven G Coca
American Journal of Physiology. Renal Physiology|December 13, 2018
"I don't get no respect": the role of chloride in acute kidney injuryJoshua L Rein, Steven G Coca
Kidney International|October 26, 2019
"Permissive AKI" with treatment of heart failureChirag R Parikh, Steven G Coca
Journal of the American Society of Nephrology : JASN|September 1, 2021
Predictors of Kidney Disease Progression in Diabetes and Precision Medicine: Something Old, Something New, and Something BorrowedGeorge Vasquez-Rios, Steven G Coca
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
Traditional urinary biomarkers in the assessment of hospital-acquired AKIMark A Perazella, Steven G Coca
Annals of Internal Medicine|August 4, 2004
Albuminuria and mortality in hypertensionSteven G Coca, Gregory K Buller
American Heart Journal|January 6, 2005
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery diseaseSteven G Coca, Gregory K Buller
Pageof 26

Showing results (21-30 of 257) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|October 3, 2003
COMET: a proposed mechanism of action to explain the results and concerns about doseSteven G Coca, Gregory K Buller
The American Journal of the Medical Sciences|October 20, 2005
The role of aldosterone blockers in the management of chronic heart failureSteven G Coca, Mark A Perazella
The New England Journal of Medicine|July 9, 2003
Eplerenone in patients with left ventricular dysfunctionSteven G Coca, Gregory K Buller
Seminars in Dialysis|March 27, 2014
Can we predict recovery from severe acute kidney injury with biomarkers?Farrukh M Koraishy, Steven G Coca
American Journal of Physiology. Renal Physiology|December 13, 2018
"I don't get no respect": the role of chloride in acute kidney injuryJoshua L Rein, Steven G Coca
Kidney International|October 26, 2019
"Permissive AKI" with treatment of heart failureChirag R Parikh, Steven G Coca
Journal of the American Society of Nephrology : JASN|September 1, 2021
Predictors of Kidney Disease Progression in Diabetes and Precision Medicine: Something Old, Something New, and Something BorrowedGeorge Vasquez-Rios, Steven G Coca
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
Traditional urinary biomarkers in the assessment of hospital-acquired AKIMark A Perazella, Steven G Coca
Annals of Internal Medicine|August 4, 2004
Albuminuria and mortality in hypertensionSteven G Coca, Gregory K Buller
American Heart Journal|January 6, 2005
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery diseaseSteven G Coca, Gregory K Buller
Pageof 26